NATIONAL BANK OF CANADA /FI/ - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 93 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
NATIONAL BANK OF CANADA /FI/ ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$383
-57.9%
1,2800.0%0.00%
Q2 2023$909
-20.7%
1,2800.0%0.00%
Q1 2023$1,147
-23.4%
1,2800.0%0.00%
Q4 2022$1,498
-85.0%
1,2800.0%0.00%
Q3 2022$10,000
+400.0%
1,280
+435.6%
0.00%
Q2 2022$2,0000.0%2390.0%0.00%
Q1 2022$2,000
+100.0%
2390.0%0.00%
Q4 2021$1,0002390.00%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Simplify Asset Management Inc. 2,700,000$823,5000.09%
683 Capital Management, LLC 2,650,000$808,2500.06%
GSA CAPITAL PARTNERS LLP 355,867$1090.01%
RBF Capital, LLC 391,265$119,3360.01%
UBS OCONNOR LLC 393,975$120,1620.00%
XTX Topco Ltd 15,597$4,7570.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 106,700$32,5440.00%
AMERIPRISE FINANCIAL INC 8,592,471$2,620,7040.00%
DRW Securities, LLC 120,365$370.00%
DFPG INVESTMENTS, LLC 32,430$10,8960.00%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders